Allurion Technologies (ALURD) Operating Income (2022 - 2026)

Allurion Technologies (ALURD) Operating Income (2022 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Abbott Laboratories 186.78 Bn 179.48 Bn 6.27 Bn 1.35 Bn
2 Stryker 131.95 Bn 129.07 Bn 3.81 Bn 936.00 Mn
3 Medtronic 111.27 Bn 102.05 Bn 6.41 Bn 1.87 Bn
4 Boston Scientific 68.58 Bn 67.13 Bn 3.61 Bn 1.10 Bn
5 Edwards Lifesciences 48.31 Bn 44.63 Bn 1.29 Bn 477.60 Mn
6 GE HealthCare Technologies 29.23 Bn 26.94 Bn 1.98 Bn 515.00 Mn
7 Dexcom 28.90 Bn 27.78 Bn 750.30 Mn 255.30 Mn
8 Smith & Nephew 28.19 Bn 27.62 Bn - -
9 Koninklijke Philips 24.33 Bn 21.29 Bn 2.01 Bn 274.25 Mn
10 Allurion Technologies 60.75 Mn 55.69 Mn 1.23 Mn -3.73 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -3.73 Mn
Dec 31, 2025 -6.26 Mn
Sep 30, 2025 -9.63 Mn
Jun 30, 2025 -6.95 Mn
Mar 31, 2025 -7.28 Mn
Dec 31, 2024 -17.12 Mn
Sep 30, 2024 -12.34 Mn
Jun 30, 2024 -9.35 Mn
Mar 31, 2024 -11.39 Mn
Dec 31, 2023 -25.74 Mn
Sep 30, 2023 -26.15 Mn
Jun 30, 2023 -13.29 Mn
Mar 31, 2023 -13.90 Mn
Dec 31, 2022 -10.15 Mn
Sep 30, 2022 -11.99 Mn
Jun 30, 2022 -4.29 Mn